Electrochemical sensors for hydrogen can be useful for development and optimization of water electrolyzers and fuel cells based on hydrogen evolution and oxidation reactions (HER and HOR). A nanometer-sized hydrogen sensor used as a tip in the scanning electrochemical microscope (SECM) can probe HER and HOR electrocatalysts and photocatalysts at the nanoscale. However, Pt tips and chemically modified nanoelectrodes previously employed for hydrogen sensing suffer from surface passivation, low amperometric signal, and stability issues. Here, the preparation of hydrogen sensors by covalently attaching ferrocene groups to the surface of Pt or carbon nanoelectrodes through oxidation of ferroceneacetate ions is reported. Mediated oxidation of hydrogen at surface-modified nanoelectrodes produces measurable and stable current suitable for amperometric measurements and SECM imaging.
{"title":"Nanosensor for Hydrogen Detection and High-Resolution Electrochemical Imaging","authors":"Shu Wu, Jean-Marc Noël, Michael V. Mirkin","doi":"10.1002/anse.202500094","DOIUrl":"https://doi.org/10.1002/anse.202500094","url":null,"abstract":"<p>Electrochemical sensors for hydrogen can be useful for development and optimization of water electrolyzers and fuel cells based on hydrogen evolution and oxidation reactions (HER and HOR). A nanometer-sized hydrogen sensor used as a tip in the scanning electrochemical microscope (SECM) can probe HER and HOR electrocatalysts and photocatalysts at the nanoscale. However, Pt tips and chemically modified nanoelectrodes previously employed for hydrogen sensing suffer from surface passivation, low amperometric signal, and stability issues. Here, the preparation of hydrogen sensors by covalently attaching ferrocene groups to the surface of Pt or carbon nanoelectrodes through oxidation of ferroceneacetate ions is reported. Mediated oxidation of hydrogen at surface-modified nanoelectrodes produces measurable and stable current suitable for amperometric measurements and SECM imaging.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146129767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muthui Martin Mwaurah, Ajitha Pratheepkumar Anuja, Tatsuo Nakagawa, Jayaraman Mathiyarasu, A. M. Vinu Mohan
A diaper-based, flexible, and miniature enzymatic biofuel cell (EBFC) is fabricated on carbon-coated conductive threads to detect glucose in the absence of a potentiostat. To construct the EBFC anode, 1,4-Naphthoquinone redox mediator is immobilized with glucose oxidase (GOx) on multi-walled carbon nanotubes. Ag/Ag2O redox couple-based cathode is developed and integrated into BFC cathode due to its ability to perform even in a limited oxygen environment. Gold nanowires (AuNWs) are prepared and utilized for electrical wiring of GOx to the electrode surface. The EBFCs performance are found to be greatly enhanced (eight fold) in the presence of AuNWs with a maximum power density of 117 μW cm−2 at an open circuit potential of 0.43 V. The EBFC shows linear increase in short-circuit currents when exposed to different glucose concentrations. This configuration enables precise glucose detection in the absence of a potentiostat. The results indicate that the sensor could detect a wide range of glucose (0.25–10 mM) in artificial urine and real human samples. The sensor exhibits remarkable selectivity toward glucose in the presence of common interferences. To validate the sensor's performance, urine and blood samples are collected from three diabetic and three healthy volunteers. The results show a good correlation between both measurements, with a Pearson correlation coefficient of 0.89, suggesting the efficiency of the smart diaper sensor for real-time urine analysis.
{"title":"Biofuel Cell-Based Potentiostat-Free Smart Diaper Sensor for Urinary Glucose Monitoring","authors":"Muthui Martin Mwaurah, Ajitha Pratheepkumar Anuja, Tatsuo Nakagawa, Jayaraman Mathiyarasu, A. M. Vinu Mohan","doi":"10.1002/anse.202500039","DOIUrl":"https://doi.org/10.1002/anse.202500039","url":null,"abstract":"<p>A diaper-based, flexible, and miniature enzymatic biofuel cell (EBFC) is fabricated on carbon-coated conductive threads to detect glucose in the absence of a potentiostat. To construct the EBFC anode, 1,4-Naphthoquinone redox mediator is immobilized with glucose oxidase (GOx) on multi-walled carbon nanotubes. Ag/Ag<sub>2</sub>O redox couple-based cathode is developed and integrated into BFC cathode due to its ability to perform even in a limited oxygen environment. Gold nanowires (AuNWs) are prepared and utilized for electrical wiring of GOx to the electrode surface. The EBFCs performance are found to be greatly enhanced (eight fold) in the presence of AuNWs with a maximum power density of 117 μW cm<sup>−2</sup> at an open circuit potential of 0.43 V. The EBFC shows linear increase in short-circuit currents when exposed to different glucose concentrations. This configuration enables precise glucose detection in the absence of a potentiostat. The results indicate that the sensor could detect a wide range of glucose (0.25–10 mM) in artificial urine and real human samples. The sensor exhibits remarkable selectivity toward glucose in the presence of common interferences. To validate the sensor's performance, urine and blood samples are collected from three diabetic and three healthy volunteers. The results show a good correlation between both measurements, with a Pearson correlation coefficient of 0.89, suggesting the efficiency of the smart diaper sensor for real-time urine analysis.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146136122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vanshika Verma, Meghana G. Kiran, Rahiel Janbaz, Rehan Deshmukh
Electrochemical DNA-based biosensors have shown great potential in the rapid and highly accurate detection of Escherichia coli (E. coli), offering advantages over conventional microbial detection techniques. By leveraging hybrid nanointerfaces, these biosensors are emerging as a promising alternative for the rapid, accurate, and affordable detection of E. coli. These biosensors offer real-time pathogen monitoring with minimal sample preparation by utilizing the high sensitivity of electrochemical transduction and the specificity of DNA hybridization. This comprehensive review covers the basic principles of electrochemical DNA biosensor functioning, transduction mechanism-based classification, and different immobilization techniques to improve biosensing performance. Significant developments in signal amplification, nanomaterial integration, and electrode surface modifications-particularly through the design of hybrid nanointerfaces, are reviewed, showing enhancements in detection stability, sensitivity, and selectivity. Additionally, the integration of nanomaterials has greatly enhanced sensor performance by improving signal stability and reducing the detection time. Despite these developments, problems with sample complexity, sensor downsizing, and practical implementation still exist. This review aims to highlight the most recent advancements, potential commercialization applications, and future directions in the field to facilitate the development of next-generation biosensors for the detection of pathogens.
{"title":"Hybrid Nanointerfaces Empower Electrochemical DNA Biosensors for Escherichia Coli Detection","authors":"Vanshika Verma, Meghana G. Kiran, Rahiel Janbaz, Rehan Deshmukh","doi":"10.1002/anse.202500084","DOIUrl":"https://doi.org/10.1002/anse.202500084","url":null,"abstract":"<p>Electrochemical DNA-based biosensors have shown great potential in the rapid and highly accurate detection of <i>Escherichia coli (E. coli)</i>, offering advantages over conventional microbial detection techniques. By leveraging hybrid nanointerfaces, these biosensors are emerging as a promising alternative for the rapid, accurate, and affordable detection of <i>E. coli</i>. These biosensors offer real-time pathogen monitoring with minimal sample preparation by utilizing the high sensitivity of electrochemical transduction and the specificity of DNA hybridization. This comprehensive review covers the basic principles of electrochemical DNA biosensor functioning, transduction mechanism-based classification, and different immobilization techniques to improve biosensing performance. Significant developments in signal amplification, nanomaterial integration, and electrode surface modifications-particularly through the design of hybrid nanointerfaces, are reviewed, showing enhancements in detection stability, sensitivity, and selectivity. Additionally, the integration of nanomaterials has greatly enhanced sensor performance by improving signal stability and reducing the detection time. Despite these developments, problems with sample complexity, sensor downsizing, and practical implementation still exist. This review aims to highlight the most recent advancements, potential commercialization applications, and future directions in the field to facilitate the development of next-generation biosensors for the detection of pathogens.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146129808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system, initially identified as a bacterial adaptive immune mechanism, has emerged as a revolutionary tool in genome editing and molecular diagnostics. This review highlights recent advancements in engineering CRISPR/Cas systems to improve specificity in nucleic acid detection, particularly in single-base differences analysis. Mainly focus on Cas protein engineering (e.g., structure-guided mutagenesis, directed evolution) and guide RNA (gRNA) optimization (e.g., mismatch introduction, chemical modifications). Integration of artificial intelligence tools, such as AlphaFold3 for structural prediction and machine learning for guide RNA design, may accelerate CRISPR/Cas system optimization. Despite progress, challenges persist in balancing specificity with efficiency and translating these technologies into clinical practice. By bridging computational innovation with experimental validation, CRISPR/Cas systems are poised to advance portable, scalable molecular diagnostics for precision medicine.
{"title":"Engineering CRISPR/Cas Systems for High-Specific Nucleic Acid Detection: Innovations, Challenges and Opportunities","authors":"Yuyang Wen, Hongli Wei, Huiling You, Jingxi Liu, Haiping Wu, Yunlong Liu","doi":"10.1002/anse.202500064","DOIUrl":"https://doi.org/10.1002/anse.202500064","url":null,"abstract":"<p>The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system, initially identified as a bacterial adaptive immune mechanism, has emerged as a revolutionary tool in genome editing and molecular diagnostics. This review highlights recent advancements in engineering CRISPR/Cas systems to improve specificity in nucleic acid detection, particularly in single-base differences analysis. Mainly focus on Cas protein engineering (e.g., structure-guided mutagenesis, directed evolution) and guide RNA (gRNA) optimization (e.g., mismatch introduction, chemical modifications). Integration of artificial intelligence tools, such as AlphaFold3 for structural prediction and machine learning for guide RNA design, may accelerate CRISPR/Cas system optimization. Despite progress, challenges persist in balancing specificity with efficiency and translating these technologies into clinical practice. By bridging computational innovation with experimental validation, CRISPR/Cas systems are poised to advance portable, scalable molecular diagnostics for precision medicine.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146136555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farbod Ebrahimi, Farshad Ebrahimi, Anjali Kumari, Saqer Al Abdullah, Kristen Dellinger
Early diagnosis of Alzheimer's disease (AD) is challenging due to the limitations of current biomarker detection methods. A customizable SERS-based aptasensor platform is presented that combines aptamer-functionalized gold nanoparticles (AuNPs) with machine learning (ML) algorithms for rapid and sensitive tau protein quantification, a key biomarker for AD. Through systematic evaluation of nanoprobes conjugated with four different tau-specific aptamer sequences, two aptamer configurations, named AT and BT, are identified as optimal candidates, demonstrating enhancement factors (EFs) of 2.12 × 103 and 1.82 × 103, respectively. This approach enables label-free detection within 30 min and integrates Random Forest (RF) and Convolutional Neural Network (CNN) models for concentration prediction of unknown samples. The RF models achieve remarkable accuracy with R2 values of 0.998 for AT and 0.9999 for BT configurations, while the CNN models demonstrate strong performance with R2 values of 0.968 (AT) and 0.986 (BT). The platform achieves a detection limit of 100 pM, well within the clinically relevant ranges. This label-free approach offers advantages in terms of rapid detection time, portability, and potential adaptability to other biomarkers. The integration of direct SERS sensing with ML algorithms for automated concentration prediction represents a promising advancement in biomarker analysis.
{"title":"AI-Assisted Customizable SERS-Based Aptasensor for Label-Free, Rapid, and Sensitive Detection of Tau: Comparative Analysis Using Random Forest and Convolutional Neural Networks","authors":"Farbod Ebrahimi, Farshad Ebrahimi, Anjali Kumari, Saqer Al Abdullah, Kristen Dellinger","doi":"10.1002/anse.202500071","DOIUrl":"https://doi.org/10.1002/anse.202500071","url":null,"abstract":"<p>Early diagnosis of Alzheimer's disease (AD) is challenging due to the limitations of current biomarker detection methods. A customizable SERS-based aptasensor platform is presented that combines aptamer-functionalized gold nanoparticles (AuNPs) with machine learning (ML) algorithms for rapid and sensitive tau protein quantification, a key biomarker for AD. Through systematic evaluation of nanoprobes conjugated with four different tau-specific aptamer sequences, two aptamer configurations, named AT and BT, are identified as optimal candidates, demonstrating enhancement factors (EFs) of 2.12 × 10<sup>3</sup> and 1.82 × 10<sup>3</sup>, respectively. This approach enables label-free detection within 30 min and integrates Random Forest (RF) and Convolutional Neural Network (CNN) models for concentration prediction of unknown samples. The RF models achieve remarkable accuracy with <i>R</i><sup>2</sup> values of 0.998 for AT and 0.9999 for BT configurations, while the CNN models demonstrate strong performance with <i>R</i><sup>2</sup> values of 0.968 (AT) and 0.986 (BT). The platform achieves a detection limit of 100 pM, well within the clinically relevant ranges. This label-free approach offers advantages in terms of rapid detection time, portability, and potential adaptability to other biomarkers. The integration of direct SERS sensing with ML algorithms for automated concentration prediction represents a promising advancement in biomarker analysis.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"6 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/anse.202500071","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146136249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hydrogen peroxide (H2O2) is an important small metabolite often quantified with commercially available multistep fluorescence-based assays. A new microtiter plate (MTP)-based platform that allows a rapid, one-step assay with a ratiometric readout function is developed. Specifically, 10-Acetyl-3,7-dihydroxyphenoxazine (ADHP) in a polyurethane-based hydrogel sensor membrane is embedded. For a ratiometric set-up, the membranes are loaded with polystyrene nanoparticles containing a Cy5-based reference which allowed for the compensation for variations in membrane thickness. These knife-coated µm-thin films are mounted onto bottomless MTPs with double-sided adhesive tape. Optimized membranes provide measurement times of 3 min upon sample addition and a limit of detection (LOD) in phosphate-buffered saline that is 10x lower than that of the ADHP-using Amplex Red commercial kit of 100 nmol L−1 H2O2. These ADHP hydrogels can be stored at room temperature for at least 22 months. Horseradish peroxidase (HRP) is nanospotted alone or together with either lactate oxidase or glucose oxidase for the detection of H2O2, lactate, and glucose, respectively. With 50 v% glycerol as cryoprotectant in the spotting solution, the HRP ADHP platform is stable for at least 13 weeks at –20 °C. Enhanced simplicity and comparable performance to multistep assays suggest that the platform can simplify MTP-based assays in the future.
{"title":"A Fluorescent Microtiter Plate-Based Detection Platform for Hydrogen Peroxide, Glucose, and Lactate","authors":"John J. Galligan, Antje J. Baeumner, Axel Duerkop","doi":"10.1002/anse.202500060","DOIUrl":"https://doi.org/10.1002/anse.202500060","url":null,"abstract":"<p>Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) is an important small metabolite often quantified with commercially available multistep fluorescence-based assays. A new microtiter plate (MTP)-based platform that allows a rapid, one-step assay with a ratiometric readout function is developed. Specifically, 10-Acetyl-3,7-dihydroxyphenoxazine (ADHP) in a polyurethane-based hydrogel sensor membrane is embedded. For a ratiometric set-up, the membranes are loaded with polystyrene nanoparticles containing a Cy5-based reference which allowed for the compensation for variations in membrane thickness. These knife-coated µm-thin films are mounted onto bottomless MTPs with double-sided adhesive tape. Optimized membranes provide measurement times of 3 min upon sample addition and a limit of detection (LOD) in phosphate-buffered saline that is 10x lower than that of the ADHP-using Amplex Red commercial kit of 100 nmol L<sup>−1</sup> H<sub>2</sub>O<sub>2</sub>. These ADHP hydrogels can be stored at room temperature for at least 22 months. Horseradish peroxidase (HRP) is nanospotted alone or together with either lactate oxidase or glucose oxidase for the detection of H<sub>2</sub>O<sub>2</sub>, lactate, and glucose, respectively. With 50 v% glycerol as cryoprotectant in the spotting solution, the HRP ADHP platform is stable for at least 13 weeks at –20 °C. Enhanced simplicity and comparable performance to multistep assays suggest that the platform can simplify MTP-based assays in the future.</p>","PeriodicalId":72192,"journal":{"name":"Analysis & sensing","volume":"5 6","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/anse.202500060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145470148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}